ERBB2 and breast carcinoma: To select the target cell line, immunoblotting was performed to identify the HER2 expression level from a series of breast cancer cell lines [SKBR-3, BT-474, MDA-MB-361, MDA-MB-453, JIMT-1] and gastric cancer cell line [NCI-N87] (Figure 6a).